Inventor · disambiguated record
Michael Mutz
Also filed as: MUTZ MICHAEL · MUTZ MICHAEL JOSEPH · STARKWEATHER HOWARD W JR
28 granted patents·27 pending applications·300 citations·filing 1976–2024
95Inventor score
Top patents by PatentIndex Score
55 records- 0195US6380227B1Fermentative preparation process for and crystal forms of cytostaticsNOVARTIS AG·Filed 2000·Granted Apr 30, 2002·49 cites·14 claims
- 0294US6194181B1Fermentative preparation process for and crystal forms of cytostaticsNOVARTIS AG·Filed 1999·Granted Feb 27, 2001·167 cites·15 claims
- 0387US7893076B2Crystalline form F of Imatinib mesylateNOVARTIS AG·Filed 2006·Granted Feb 22, 2011·3 cites·8 claims
- 0484US2024239743A11-(4-{1-[(e)-4-cyclohexyl-3-trifluoromethylbenzyloxyimino]-ethyl}-2-ethyl-benzyl)-azetidine-3-carboxylic acid, (e)-but-2-enedioic acidNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0581US8349852B2Quinazolinone derivatives useful as vanilloid antagonistsNOVARTIS AG·Filed 2010·Granted Jan 8, 2013·9 cites·5 claims
- 0679US8530522B2Organic compoundsJORDINE GUIDO·Filed 2009·Granted Sep 10, 2013·4 cites·5 claims
- 0778US4078014AComposition of polyamide, polyethylene ionomer copolymerDU PONT·Filed 1976·Granted Mar 7, 1978·28 cites·9 claims
- 0876US4217430AGraft copolymer of neutralized acid copolymer trunk and polyamide oligomeric branches and method for making such copolymerDU PONT·Filed 1978·Granted Aug 12, 1980·29 cites·29 claims
- 0975US2023357142A91-(4-{1-[(e)-4-cyclohexyl-3-trifluoromethylbenzyloxyimino]-ethyl}-2-ethyl-benzyl)-azetidine-3-carboxylic acid, (e)-but-2-enedioic acidNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1074US6656711B2Fermentative preparation process for and crystal forms of cytostaticsNOVARTIS AG·Filed 2002·Granted Dec 2, 2003·5 cites·6 claims
- 1172US7879860B2Delta and epsilon crystal forms of Imatinib mesylateNOVARTIS AG·Filed 2006·Granted Feb 1, 2011·1 cites·27 claims
- 1271US8680146B2Organic compoundsJORDINE GUIDO·Filed 2009·Granted Mar 25, 2014·1 cites·7 claims
- 1371US8198435B2Crystal form of N-benzoyl-staurosporineHOEHN PASCALE·Filed 2005·Granted Jun 12, 2012·2 cites·16 claims
- 1466US8513256B2Salt forms of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamideBUERGER HANS MICHAEL·Filed 2012·Granted Aug 20, 2013·1 cites·4 claims
- 1566US2021323915A1Hemifumarate salt of 1-[4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-benzyl]-azetidine-3-carboxylic acidNOVARTIS AG·Filed 2020·Application pending·0 cites
- 1664US8946272B2Plymorphic forms of deferasirox (ICL670A)MUTZ MICHAEL·Filed 2013·Granted Feb 3, 2015·0 cites·1 claims
- 1764US8710216B2Organic compoundsHOEHN PASCALE·Filed 2012·Granted Apr 29, 2014·1 cites·3 claims
- 1864US8153672B2Polymorphic forms of deferasirox (ICL670A)MUTZ MICHAEL·Filed 2007·Granted Apr 10, 2012·0 cites·8 claims
- 1962US8198289B2Crystal form H imatinib mesylate for pharmaceutical useMUTZ MICHAEL·Filed 2011·Granted Jun 12, 2012·0 cites·8 claims
- 2062US8163747B2Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide and formulations comprising these formsDRYSDALE MARTIN JAMES·Filed 2008·Granted Apr 24, 2012·0 cites·17 claims
- 2162US2012115840A1Hemifumarate salt of 1-[4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-benzyl]-azetidine-3-carboxylic acidCISZEWSKI LECH·Filed 2009·Application pending·0 cites
- 2261US8633213B2Crystalline form F of imatinib mesylateMUTZ MICHAEL·Filed 2012·Granted Jan 21, 2014·0 cites·2 claims
- 2361US8436030B2Polymorphic forms of deferasirox (ICL670A)MUTZ MICHAEL·Filed 2012·Granted May 7, 2013·0 cites·8 claims
- 2460US8846706B2Crystalline form K of imatinib mesylateMUTZ MICHAEL·Filed 2011·Granted Sep 30, 2014·0 cites·2 claims
- 2560US8592440B2Crystalline form I of imatinib mesylateMUTZ MICHAEL·Filed 2011·Granted Nov 26, 2013·0 cites·7 claims
- 2660US8507515B2Crystalline form G of imatinib mesylateMUTZ MICHAEL·Filed 2011·Granted Aug 13, 2013·0 cites·7 claims
- 2760US2009326239A1Fermentative preparation process for and crystal forms of cytostaticsHOFMANN HANS·Filed 2009·Application pending·0 cites
- 2858US2010178336A1Stabilized amorphous forms of imatinib mesylateNOVARTIS AG·Filed 2008·Application pending·0 cites
- 2958US2018118678A1Hemifumarate salt of 1-[4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-benzyl]-azetidine-3-carboxylic acidNOVARTIS AG·Filed 2017·Application pending·0 cites
- 3056US8487095B2Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-iso-propyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide and formulations comprising these formsDRYSDALE MARTIN JAMES·Filed 2012·Granted Jul 16, 2013·0 cites·3 claims
- 3155US7101702B2Fermentative preparation process for and crystal forms of cytostaticsNOVARTIS AG·Filed 2003·Granted Sep 5, 2006·0 cites·3 claims
- 3255US2007197611A1Fermentative preparation process for and crystal forms of cytostaticsHOFMANN HANS·Filed 2007·Application pending·0 cites
- 3355US2004142990A1Fermentative preparation process for and crystal forms of cytostaticsFiled 2004·Application pending·0 cites
- 3454US12459902B2Crystalline forms of 4-(7-hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile and formulations thereofBAUSCH & LOMB IRELAND LTD·Filed 2021·Granted Nov 4, 2025·0 cites·20 claims
- 3554US2014005162A1Hemifumarate salt of 1-[4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-benzyl]-azetidine-3-carboxylic acidCISZEWSKI LECH·Filed 2013·Application pending·0 cites
- 3653US2008249104A1Salt Forms of 4- (4-Methylpiperazin-1-Ylmethyl) -N- [4-Methyl-3- (4-Pyridin-3-Yl) Pyrimidin-2-Ylamino) Phenyl]- BenzamideBURGER HANS MICHAEL·Filed 2005·Application pending·0 cites
- 3753US2025011307A1Crystalline forms of biaryl yap/taz-tead protein-protein interaction inhibitorsNOVARTIS AG·Filed 2022·Application pending·0 cites
- 3852US2013022672A1Stabilized Amorphous Forms of Imatinib MesylateNOVARTIS AG·Filed 2012·Application pending·0 cites
- 3952US2003194787A1Fermentative preparation process for and crystal forms of cytostaticsFiled 2003·Application pending·0 cites
- 4052US2013296556A1Acid Addition Salts, Hydrates and Polymorphs of 5-(2,4-Dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic Acid Ethylamide and Formulations Comprising These FormsDRYSDALE MARTIN JAMES·Filed 2013·Application pending·0 cites
- 4150US8178566B2Crystal form of epothilone B and use in pharmaceutical compositionsKUESTERS ERNST·Filed 2007·Granted May 15, 2012·0 cites·5 claims
- 4250US2025353847A1Crystalline forms of an akric3 dependent kars inhibitorNOVARTIS AG·Filed 2023·Application pending·0 cites
- 4349US2014051853A1Salt forms of 4-(4-Methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamideBUERGER HANS MICHAEL·Filed 2013·Application pending·0 cites
- 4449US2014323495A1Stabilized Amorphous Forms of Imatinib MesylateGONCALVES ELISABETE·Filed 2014·Application pending·0 cites
- 4549US2014235722A1Organic CompoundsJORDINE GUIDO·Filed 2014·Application pending·0 cites
- 4648US2014051766A1Organic CompoundsJORDINE GUIDO·Filed 2013·Application pending·0 cites
- 4748US2015175536A1Hemifumarate salt of 1-[4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-benzyl]-azetidine-3-carboxylic acidCISZEWSKI LECH·Filed 2015·Application pending·0 cites
- 4847US2010286081A15-amino-3-(2',3'-di-o-acetyl-beta-d-ribofuranosyl)-3h-thiazolo[4,5-d] pyrimidin-2-oce salts and crystalline formsANADYS PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 4946US2013225598A1Stabilized Amorphous Forms of Imatinib MesylateGONCALVES ELISABETE·Filed 2013·Application pending·0 cites
- 5045US7683048B2Polymorphis of a known thiophenecarboxylic acid dodecahydrocyclopenta (a) phenanthrenyl esterNOVARTIS AG·Filed 2003·Granted Mar 23, 2010·0 cites·10 claims
Showing the top 50 of 55 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →